Trial Profile
A Phase I, Single Ascending Dose Trial to Examine the Safety and Pharmacodynamic Effects of CD-NP
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Cenderitide (Primary)
- Indications Heart failure
- Focus Adverse reactions; Pharmacodynamics
- 01 Jun 2009 Pharmacodynamic results published in Journal of Clinical Pharmacology.
- 29 Aug 2007 New trial record.